The American University in Cairo (AUC) and Minapharm Pharmaceuticals announced a new strategic partnership to strengthen ...

Get a Free Sample PDF copy of the report @- The trajectory of the Epigenetics Market is shaped by a myriad of factors. Firstly, the growing application of epigenetics in non-oncology diseases and the ...

Nothing against high-quality service! Just the contrary – high-level service is one of the indicators of a nation’s social ...

The coming era of biosecurity will demand a broader and more adaptive approach as AI, powerful biological engineering ...

Results from SCOPE to date have enabled Scancell to select Immunobody iSCIB1+, administered needle-free intramuscularly, for further development in patients with selected human leukocyte antigen (HLA) ...

The global bioreactor market is projected to grow at a compound annual growth rate (CAGR) of around 7%, driven by the rising ...

We are pleased to welcome Dr. Lee and Dr. Murphy to our Board at an important time for Century as we execute with discipline and focus to bring our most differentiated iPSC-derived cell therapy ...

Once issued, this new U.S. Patent will expand the scope of Enveric’s EVM301 patent portfolio of potential neuroplastogenic ...

Companies who run their early-stage clinical development outside the U.S. would “experience higher fees” according to an FDA ...

China's systematic intellectual property theft campaign poses unprecedented threats to American national security and ...

An update from Scancell Holdings ( ($GB:SCLP) ) is now available. Scancell Holdings has announced positive updated data from its SCOPE Phase 2 ...

(Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for ...